柬埔寨皮内狂犬病暴露后预防可缩短疗程且对临床结局无显著影响
该回顾性研究追踪2003-2014年柬埔寨3318名接受皮内Vero细胞疫苗暴露后预防者,≥6个月随访显示,被确诊狂犬病犬咬伤者生存率99.83%(95%CI 99.49-99.96%),3次与4次以上接种者生存无显著差异,但研究把握度有限(49%)。
要点
- 被确诊狂犬病犬咬伤后接受皮内暴露后预防者生存率达99.83%。
- 3次与4次以上接种方案生存率无显著差异,但研究把握度仅49%。
- 现行4次/1个月皮内方案可缩短为3次/1周,未检测到额外风险。
核心结论
- 皮内狂犬病暴露后预防从4次/1个月缩短为3次/1周对临床结局无显著影响,但研究把握度有限。
研究设计与样本
- 回顾性研究,纳入2003-2014年柬埔寨3318名被狂犬病犬或疑似病犬咬伤后接受皮内Vero细胞疫苗暴露后预防者。
- 通过外部专家小组审查口头尸检报告判定狂犬病死亡,随访至≥6个月。
主要发现
- 被确诊狂犬病犬咬伤者中1591人(91.49%)接受4次以上接种,129人(7.42%)接受3次接种。
- 被确诊狂犬病犬咬伤者中3人死于 probable rabies,总生存率99.83%(95%CI 99.49-99.96%)。
- 3次与4次以上接种者(含或不含狂犬病免疫球蛋白)生存率无显著差异。
关键数值与推荐
- 被确诊狂犬病犬咬伤后接受暴露后预防者生存率99.83%(95%CI 99.49-99.96%)。
- 3次与4次以上接种方案生存率无显著差异,研究把握度49%。
临床怎么用
- 狂犬病预防中心可采用3次/1周皮内方案替代4次/1个月方案,并建立临床随访系统监测缩短疗程的实施。
- 该方案可用现有剂量治疗更多患者(增加33%),降低直接和间接费用。
局限性
- 研究为回顾性设计,把握度有限(49%)。
- 513人失访,可能影响结果可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rabies causes 60,000 deaths worldwide annually. Rabies post-exposure prophylaxis is highly effective but often geographically and financially beyond reach in endemic developing countries. We conducted a retrospective study on clinical outcome at ≥6 months in 3318 Cambodians who received intradermal Vero cell vaccine post-exposure prophylaxis after a bite by a rabid or sick-looking but untested dog in 2003-2014. An external expert panel examined verbal autopsy reports to identify rabies deaths. 1739 (93.65%) persons bitten by rabid- and 1066 (72.96%) bitten by sick-looking but untested dogs were traced and 513 were lost to follow-up. Among the former, 1591 (91.49%) and 129 (7.42%) patients referred for 4+ and 3 post-exposure prophylaxis sessions, respectively. Three persons died of probable rabies so that the overall percentage of survival was 99.83% (95% exact confidence interval: 99.49-99.96%) in post-exposure prophylaxis recipients bitten by confirmed rabid dogs. No significant difference was found in survival among patients who received 3 vs. 4+ sessions (with or without rabies immunoglobin). The power of the study, however, was limited. The current four sessions/one month intradermal regimen can be reduced to a three sessions/one week at no detectable added risk to patients, with the limitation of study power at 49%. A clinical follow-up system should be adopted by rabies prevention centers, especially to monitor implementation of an abridged course. The Institut Pasteur in Cambodia regimen will improve vaccine equity by treating 33% more patients with available doses, reduce direct cost of vaccination, transportation and other indirect costs to vaccinees.
引用
- Tarantola A, Ly S, Chan M, et al. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014. Vaccine. 2018. PMID: 30454946. doi:10.1016/j.vaccine.2018.10.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。